Staurosporinone

Staurosporinone

SCHEMBL29374983

O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K11 Q16584 7/20 1.00
▸ MAP3K9 P80192 6/20 1.00
▸ PRKCA P17252 4/20 1.00
▸ PRKCQ Q04759 3/20 1.00
▸ PRKCD Q05655 3/20 1.00
▸ GLI1 P08151 2/20 1.00
▸ GLI2 P10070 2/20 1.00
▸ PRKD3 O94806 2/20 1.00
▸ PRKCG P05129 2/20 1.00
▸ PRKCB P05771 2/20 1.00
▸ PRKCH P24723 2/20 1.00
▸ PRKCI P41743 2/20 1.00
▸ PRKCE Q02156 2/20 1.00
▸ PRKCZ Q05513 2/20 1.00
▸ PRKD1 Q15139 2/20 1.00
▸ CDK4 P11802 1/20 1.00
▸ CTRB1 P17538 1/20 1.00
▸ PRKACA P17612 1/20 1.00
▸ PRKACG P22612 1/20 1.00
▸ PRKACB P22694 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Staurosporinone SCHEMBL5440281 1.00 MAP3K11 (1.00) MAP3K11MAP3K9PRKCAPRKCQPRKCD
Staurosporinone SCHEMBL29389399 1.00 MAP3K11 (1.00) MAP3K11MAP3K9PRKCAPRKCQPRKCD
SCHEMBL9263371 0.88 MAP3K11 (0.78) MAP3K11MAP3K9PRKCAPRKCQPRKCD
SCHEMBL9270827 0.88 MAP3K11 (0.78) MAP3K11MAP3K9PRKCAPRKCQPRKCD
SCHEMBL9260091 0.85 ROCK2 (0.78) MAP3K11MAP3K9PRKCAPRKCQPRKCD
SCHEMBL9263506 0.85 ROCK2 (0.78) MAP3K11MAP3K9PRKCAPRKCQPRKCD
SCHEMBL13639843 0.83 MAP3K11 (1.00) MAP3K11MAP3K9PRKCAPRKCQPRKCD
SCHEMBL13639845 0.83 MAP3K11 (1.00) MAP3K11MAP3K9PRKCAPRKCQPRKCD
SCHEMBL13140090 0.83 MAP3K11 (1.00) MAP3K11MAP3K9PRKCAPRKCQPRKCD
SCHEMBL13431719 0.82 MAP3K11 (0.69) MAP3K11MAP3K9PRKCAPRKCQPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220169609-A1 INDOLE-YNONE MEDIATED BENZOANNULATION PROCESS FOR THE PREPARATION OF CARBAZOLES, CARBAZOMYCIN A, CALOTHRIXIN B AND STAUROSPORINONE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2022-06-02 — — US claimed
US-20220125834-A1 LOCALIZED DELIVERY OF THERAPEUTIC AGENTS Nostopharma, LLC 2022-04-28 — — US claimed
EP-3947333-A1 INDOLE-YNONE MEDIATED BENZOANNULATION PROCESS FOR THE PREPARATION OF CARBAZOLES- CARBAZOMYCIN A, CALOTHRIXIN B AND STAUROSPORINONE Council of Scientific & Industrial Research (IN) 2022-02-09 — — EP claimed
EP-4713340-A2 COMPOSITIONS AND METHODS FOR PEPTIDE-BASED MODULATORS OF HUMAN PAPILLOMAVIRUS ONCOPROTEIN E6 Calico Life Sciences LLC (US) 2026-03-25 — — EP disclosed
US-12459893-B2 Indole-ynone mediated benzoannulation process for the preparation of carbazoles, carbazomycin A, calothrixin B and staurosporinone COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2025-11-04 — — US disclosed
US-12459893-B2 Indole-ynone mediated benzoannulation process for the preparation of carbazoles, carbazomycin A, calothrixin B and staurosporinone COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2025-11-04 — — US disclosed
US-12459893-B2 Indole-ynone mediated benzoannulation process for the preparation of carbazoles, carbazomycin A, calothrixin B and staurosporinone COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2025-11-04 — — US disclosed
US-20250304916-A1 METHODS AND COMPOSITIONS FOR GENERATING VASCULAR LEPTOMENINGEAL CELLS TRAILHEAD BIOSYSTEMS INC (US) 2025-10-02 — — US disclosed
WO-2025111511-A2 REVERSIBLY REACTIVE AFFINITY SELECTION MASS SPECTROMETRY AND USES THEREOF CALICO LIFE SCIENCES LLC (US) 2025-05-30 — — WO disclosed
US-12209092-B2 Inhibitors of GLI1 as therapeutic agents NEW YORK UNIVERSITY (US) 2025-01-28 — — US disclosed
EP-3609500-B1 TREATMENT OF ADIPOCYTES MELIOR PHARMACEUTICALS I INC (US) 2024-11-13 — — EP disclosed
US-11377636-B2 Endogenous retrovirus transcription as a marker for primate naive pluripotent stem cells MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (DE) 2022-07-05 — — US disclosed
US-20220186227-A1 Therapeutic Targets for Oncogenic KRAS-Dependent Cancers UNIVERSITY OF MASSACHUSETTS 2022-06-16 — — US disclosed
US-20220169609-A1 INDOLE-YNONE MEDIATED BENZOANNULATION PROCESS FOR THE PREPARATION OF CARBAZOLES, CARBAZOMYCIN A, CALOTHRIXIN B AND STAUROSPORINONE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2022-06-02 — — US disclosed
US-20220169609-A1 INDOLE-YNONE MEDIATED BENZOANNULATION PROCESS FOR THE PREPARATION OF CARBAZOLES, CARBAZOMYCIN A, CALOTHRIXIN B AND STAUROSPORINONE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2022-06-02 — — US disclosed
US-20220169609-A1 INDOLE-YNONE MEDIATED BENZOANNULATION PROCESS FOR THE PREPARATION OF CARBAZOLES, CARBAZOMYCIN A, CALOTHRIXIN B AND STAUROSPORINONE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2022-06-02 — — US disclosed
US-20220125834-A1 LOCALIZED DELIVERY OF THERAPEUTIC AGENTS Nostopharma, LLC 2022-04-28 — — US disclosed
EP-3947333-A1 INDOLE-YNONE MEDIATED BENZOANNULATION PROCESS FOR THE PREPARATION OF CARBAZOLES- CARBAZOMYCIN A, CALOTHRIXIN B AND STAUROSPORINONE Council of Scientific & Industrial Research (IN) 2022-02-09 — — EP disclosed
EP-3947333-A1 INDOLE-YNONE MEDIATED BENZOANNULATION PROCESS FOR THE PREPARATION OF CARBAZOLES- CARBAZOMYCIN A, CALOTHRIXIN B AND STAUROSPORINONE Council of Scientific & Industrial Research (IN) 2022-02-09 — — EP disclosed
EP-3947333-A1 INDOLE-YNONE MEDIATED BENZOANNULATION PROCESS FOR THE PREPARATION OF CARBAZOLES- CARBAZOMYCIN A, CALOTHRIXIN B AND STAUROSPORINONE Council of Scientific & Industrial Research (IN) 2022-02-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12209092-B2 Inhibitors of GLI1 as therapeutic agents GLI1, GLI2, SHH MAP3K11 2207/4885MAP3K9 2437/4885PRKCA 448/4885
US-12459893-B2 Indole-ynone mediated benzoannulation process for the preparation of carbazoles, carbazomycin A, calothrixin B and staurosporinone CYC1, CYCS, CANX MAP3K11 2101/4885MAP3K9 2007/4885PRKCA 1509/4885
US-20220169609-A1 INDOLE-YNONE MEDIATED BENZOANNULATION PROCESS FOR THE PREPARATION OF CARBAZOLES, CARBAZOMYCIN A, CALOTHRIXIN B AND STAUROSPORINONE CYC1, CYCS, CANX MAP3K11 2101/4885MAP3K9 2007/4885PRKCA 1509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback